文献速递重症综合管理与镇静镇痛

优化ICU患者管理中临床药师团队整合:药师与患者比例多中心探索的依据、研究设计与方法

Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio.
PubMed 文献 · Crit Care Explor · 2023-08-25
一句话结论多中心观察性队列研究将纳入2万例危重患者,探讨ICU临床药师工作负荷(药师与患者比例、药师临床负担指数)与患者病死率、住院时间等结局的关系。

该研究为多中心观察性队列研究,目标纳入20,000例危重患者,由参与研究的重症监护药师纳入在ICU管理的患者。数据收集分前瞻性和回顾性两个观察阶段:前瞻性阶段由重症监护药师记录每日工作负荷数据(如患者数、查房团队数),回顾性阶段记录患者人口学特征、疾病严重程度、用药方案复杂性和结局。主要结局为病死率,将采用多水平多元 logistic 回归(逐步变量选择剔除不显著协变量)、有监督和无监督机器学习技术以及贝叶斯分析等多种方法探索。研究旨在确定以药师与患者比例和药师临床负担指数衡量的药师工作负荷与以患者为中心的结局(包括病死率和住院时间)之间的关系。

要点

  • 研究目标纳入20,000例危重患者,探讨ICU临床药师工作负荷与患者结局的关系。
  • 主要结局为病死率,次要结局包括住院时间等以患者为中心的结局。
  • 工作负荷以药师与患者比例和药师临床负担指数衡量。
  • 数据收集分前瞻性阶段(每日记录患者数、查房团队数等工作负荷数据)和回顾性阶段(记录人口学、疾病严重程度、用药复杂性及结局)。
  • 统计分析采用多水平多元 logistic 回归、机器学习和贝叶斯分析等多种方法。

适用人群与场景

  • 参与研究的重症监护药师纳入在ICU管理的危重患者,目标总样本量为20,000例。

研究设计与关键结果

  • 研究设计为多中心观察性队列研究,目标纳入20,000例危重患者。
  • 数据收集分两个观察阶段:前瞻性阶段由重症监护药师记录每日工作负荷数据(如患者数、查房团队数);回顾性阶段记录患者人口学特征、疾病严重程度、用药方案复杂性和结局。
  • 主要结局为病死率,将采用多水平多元 logistic 回归(逐步变量选择剔除不显著协变量)、有监督和无监督机器学习技术以及贝叶斯分析进行探索。
  • 研究旨在确定以药师与患者比例和药师临床负担指数衡量的药师工作负荷与患者结局(包括病死率和住院时间)之间的关系。

证据类型、等级与局限

  • 证据类型:多中心观察性队列研究的研究方案。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The workload of healthcare professionals including physicians and nurses in the ICU has an established relationship to patient outcomes, including mortality, length of stay, and other quality indicators; however, the relationship of critical care pharmacist workload to outcomes has not been rigorously evaluated and determined. The objective of our study is to characterize the relationship of critical care pharmacist workload in the ICU as it relates to patient-centered outcomes of critically ill patients.

METHODS: Optimizing Pharmacist Team-Integration for ICU patient Management is a multicenter, observational cohort study with a target enrollment of 20,000 critically ill patients. Participating critical care pharmacists will enroll patients managed in the ICU. Data collection will consist of two observational phases: prospective and retrospective. During the prospective phase, critical care pharmacists will record daily workload data (e.g., census, number of rounding teams). During the retrospective phase, patient demographics, severity of illness, medication regimen complexity, and outcomes will be recorded. The primary outcome is mortality. Multiple methods will be used to explore the primary outcome including multilevel multiple logistic regression with stepwise variable selection to exclude nonsignificant covariates from the final model, supervised and unsupervised machine learning techniques, and Bayesian analysis.

RESULTS: Our protocol describes the processes and methods for an observational study in the ICU.

CONCLUSIONS: This study seeks to determine the relationship between pharmacist workload, as measured by pharmacist-to-patient ratio and the pharmacist clinical burden index, and patient-centered outcomes, including mortality and length of stay.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Keats K, Sikora A, Heavner MS, et al. Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio. Crit Care Explor. 2023. PMID: 37644971. doi:10.1097/CCE.0000000000000956

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。